Activity-Dependent Neuroprotective Protein Fragment 74-81, mouse, rat
| Title | Journal |
|---|---|
| From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease. | Journal of Alzheimer's disease : JAD 20120101 |
| Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model. | Neurobiology of disease 20111201 |
| NAP prevents acute cerebral oxidative stress and protects against long-term brain injury and cognitive impairment in a model of neonatal hypoxia-ischemia. | Neurobiology of disease 20111001 |
| Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain. | Peptides 20110601 |
| Neuroprotective fractalkine in fetal alcohol syndrome. | American journal of obstetrics and gynecology 20110501 |
| Prevention of learning deficit in a Down syndrome model. | Obstetrics and gynecology 20110201 |
| NAP (davunetide) provides functional and structural neuroprotection. | Current pharmaceutical design 20110101 |
| Microtubules (tau) as an emerging therapeutic target: NAP (davunetide). | Current pharmaceutical design 20110101 |
| Effects of ethanol and NAP on cerebellar expression of the neural cell adhesion molecule L1. | PloS one 20110101 |
| Expression of peptide NAP in rat retinal Müller cells prevents hypoxia-induced retinal injuries and promotes retinal neurons growth. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100701 |
| NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia. | Peptides 20100701 |
| Prevention of the alcohol-induced changes in brain-derived neurotrophic factor expression using neuroprotective peptides in a model of fetal alcohol syndrome. | American journal of obstetrics and gynecology 20100501 |
| Reversal of alcohol-induced learning deficits in the young adult in a model of fetal alcohol syndrome. | Obstetrics and gynecology 20100201 |
| Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis. | Neuroimmunomodulation 20100101 |
| NAP prevents hippocampal oxidative damage in neonatal rats subjected to hypoxia-induced seizures. | Neurobiology of disease 20091201 |
| The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy. | Journal of neurochemistry 20091201 |
| Short neuroprotective peptides, ADNF9 and NAP, are structurally disordered and monomeric in PBS. | International journal of biological macromolecules 20090701 |
| Prenatal NAP+SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-D-aspartic acid and gamma-aminobutyric acid receptors. | American journal of obstetrics and gynecology 20090501 |
| Activity-dependent neuroprotective protein-derived peptide, NAP, preventing alcohol-induced apoptosis in fetal brain of C57BL/6 mouse. | Neuroscience 20090218 |
| The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20080901 |
| NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42). | BMC neuroscience 20080101 |
| NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell. | Current Alzheimer research 20071201 |
| The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol. | Journal of neurochemistry 20071001 |
| NAP protects hippocampal neurons against multiple toxins. | Peptides 20071001 |
| Understanding the mechanism of learning enhancement: NMDA and GABA receptor expression. | American journal of obstetrics and gynecology 20070901 |
| [Effect of neuropeptide NAP on cultured neuroepithelial cells from rabbit retina]. | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20070601 |
| Neuroprotective peptides prevent some alcohol-induced alteration in gamma-aminobutyric acid A-beta3, which plays a role in cleft lip and palate and learning in fetal alcohol syndrome. | American journal of obstetrics and gynecology 20070301 |
| NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis. | Current pharmaceutical design 20070101 |
| Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage. | Journal of molecular neuroscience : MN 20070101 |
| Prevention of alcohol-induced learning deficits in fetal alcohol syndrome mediated through NMDA and GABA receptors. | American journal of obstetrics and gynecology 20060301 |
| [Review of neurobehavioral effects of alcohol-related neurodevelopmental disorder in an animal model]. | Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20060201 |
| Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases. | Journal of neural transmission. Supplementum 20060101 |
| Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome. | American journal of obstetrics and gynecology 20050901 |
| The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro. | Investigative ophthalmology & visual science 20050301 |
| Peptide-mediated protection from ethanol-induced neural tube defects. | Developmental neuroscience 20050101 |
| Synergistic effects of the peptide fragment D-NAPVSIPQ on ethanol inhibition of synaptic plasticity and NMDA receptors in rat hippocampus. | Neuroscience 20050101 |
| NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). | CNS drug reviews 20050101 |
| Ethanol antagonist peptides: structural specificity without stereospecificity. | The Journal of pharmacology and experimental therapeutics 20040601 |
| Protective peptides that are orally active and mechanistically nonchiral. | The Journal of pharmacology and experimental therapeutics 20040601 |
| NAP mechanisms of neuroprotection. | Journal of molecular neuroscience : MN 20040101 |
| Characterization of competitive inhibitors for the transferase activity of Pseudomonas aeruginosa exotoxin A. | Journal of enzyme inhibition and medicinal chemistry 20020801 |
| Vasoactive intestinal peptide and related molecules induce nitrite accumulation in the extracellular milieu of rat cerebral cortical cultures. | Neuroscience letters 20010720 |
| Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. | The Journal of pharmacology and experimental therapeutics 20010501 |
| Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. | The Journal of pharmacology and experimental therapeutics 20000601 |